FundedIQ
Biotechnology

Capra Biosciences: Funding, Investors & Team (Oct 2026)

Capra Biosciences is a biotechnology organization bridling science for effective and low-carbon creation of regular synthetics. It creates bioreactor innovation intended to make the development of synthetic items more productive. The organization fostered a biofilm bioreactor which can possibly fundamentally decrease the downstream handling necessities and expenses innate in the bio-assembling of items like powers. Capra Biosciences was established in 2020 and is settled in Alexandria, VA.

www.caprabiosciences.com LinkedIn Alexandria, United States 1-10 employees
Biotechnology Chemical Life Science
Total raised
$7.2M
Rounds
3
Latest
Seed
Dec 2023

Capra Biosciences has raised $7.2M across 3 funding rounds on record, the most recent a Seed of $3.4M announced in Dec 2023.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Capra Biosciences Company Profile and Key Stats

Total funding raised
$7.2M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Seed
$3.4M in Dec 2023
Employees
1-10
reported band
Headquarters
Alexandria, United States

Latest funding round on record: Dec 2023.

Capra Biosciences Funding Rounds

Date
Round
Amount
Seed
$3.4M
Undisclosed round
$2.0M
Pre-Seed
$1.8M

Capra Biosciences raised $1.8M in a Pre-Seed announced in Jun 2022.

10 months later, an undisclosed round of $2.0M was announced in Apr 2023.

8 months later, a Seed of $3.4M was announced in Dec 2023.

Capra Biosciences Founders and Leadership Team

Name
Role
Contact
Andrew Magyar
Founder
Locked

Contact details for the Capra Biosciences team: 1 of 1 has an email address on file.

Start 14-day free trial →

Capra Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
17,054
$3.1M

Capra Biosciences' latest round of $3.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Capra Biosciences in Biotechnology and Alexandria

Companies Similar to Capra Biosciences

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Capra Biosciences Funding FAQs

What does Capra Biosciences do?

Capra Biosciences is a biotechnology organization bridling science for effective and low-carbon creation of regular synthetics. It creates bioreactor innovation intended to make the development of synthetic items more productive. The organization fostered a biofilm bioreactor which can possibly fundamentally decrease the downstream handling necessities and expenses innate in the bio-assembling of items like powers. Capra Biosciences was established in 2020 and is settled in Alexandria, VA.

How much funding has Capra Biosciences raised?

Capra Biosciences has raised $7.2M across 3 rounds on record. The most recent is a Seed of $3.4M announced in Dec 2023.

When did Capra Biosciences last raise funding?

Capra Biosciences' most recent funding round on record is a Seed of $3.4M, announced in Dec 2023.

Who founded Capra Biosciences?

FundedIQ lists Andrew Magyar (Founder) at Capra Biosciences.

Where is Capra Biosciences headquartered?

Capra Biosciences is based in Alexandria, Virginia, United States.

How many employees does Capra Biosciences have?

Capra Biosciences is in the 1-10 employee band.

How does Capra Biosciences' funding compare to other Biotechnology startups?

Capra Biosciences' latest round of $3.4M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Capra Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Capra Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.